Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2019-08-20 Investor Presentation
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 85% confidence The document is very short (295 characters) and appears to be a schedule or announcement of an investor conference meeting on August 21, 2019. It does not contain any financial data, detailed report content, or regulatory filings. It is not a report itself but rather an announcement or schedule related to investor interaction. Given the content and length, it best fits the category of an Investor Presentation (IP) or possibly a Regulatory Filing (RNS) if it were a brief announcement. However, since it specifically mentions an investor conference and types of interaction, it aligns more closely with Investor Presentation (IP).
2019-08-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Laurus Labs for Q1 FY2020, dated August 5, 2019. It includes detailed discussions by company executives about quarterly financial results, business highlights, product approvals, market share, and outlook. The presence of a moderator, Q&A session, and detailed financial and operational commentary are characteristic of earnings call transcripts. There is no indication that this is a formal earnings release (which would be a brief announcement), nor is it a full annual or interim report. The document is not a presentation, regulatory filing, or other report type. Therefore, the document fits the category of a Call Transcript (CT).
2019-08-08 English
Investor Presentation
Regulatory Filings
2019-08-02 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the Q1 FY20 financial results of Laurus Labs Limited. It contains key financial metrics such as revenue, EBITDA, PAT, and EPS for the quarter, along with management commentary on business performance and regulatory updates. The document is dated August 2, 2019, and focuses on quarterly financial results and operational highlights. It is not a full interim or quarterly report with detailed financial statements or analysis, but rather an initial announcement of quarterly financial results. Therefore, it fits the definition of an Earnings Release (ER). The document length (6122 characters) and content support this classification with high confidence. Q1 2020
2019-08-02 English
Financial Result Updates
Regulatory Filings
2019-08-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document text contains details about a conference call, including timing and dial-in numbers for various locations. There is no financial data, report content, or regulatory information. The presence of conference dial-in numbers and timing strongly indicates this is a transcript or announcement related to a company conference call, likely an earnings or investor call. Given the content, the most appropriate classification is a Call Transcript (CT). The document length is short but contains relevant call information, not just an announcement or link.
2019-07-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.